Centennial Pharmacy Services Becomes the First Pharmacy in the Nation to Receive Accreditation for Long-Term Care at Home

Centennial Pharmacy Services Becomes the First Pharmacy in the Nation to Receive Accreditation for Long-Term Care at Home

Philadelphia, PA – Centennial Pharmacy Services is thrilled to announce its achievement of becoming the first pharmacy in the United States to receive provisional LTC@Home Pharmacy Accreditation. This provisional status

Read More

Haven Skin LLC to Launch Skincare Brand HAVEN with Focus on Clean Ingredients

St. Pete, FL – April 16, 2025 – Haven Skin LLC, a Florida-based company founded by content creator and University of Florida student Haven Lough, has announced its plan to

Read More

Viltrox Launches Full-Frame Ultra-Large-Aperture Autofocus Prime Lens: AF 35mm F1.2 LAB FE

Defines a new standard in full-frame, ultra-large-aperture 35mm lenses Shenzhen, China – April 16, 2025 – Viltrox is pleased to announce the launch of a new full-frame ultra-large-aperture autofocus prime

Read More

US Edge Computing Market 2029 Future Trends, Opportunities, Top Key Companies, Driving Factors & Scope

IBM (US), HPE (US), Microsoft (US), Dell Technologies (US), Google (US), AWS (US), Cisco (US), NVIDIA (US), Intel (US), Huawei (China), VMware (US), Nokia (Finland), Fastly (US), ADLINK Technology (Taiwan),

Read More

Psoriasis Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Medication, NDA Approval, IND, Mechanism of Action, Route of Administration by DelveInsight

Psoriasis Clinical Trials Psoriasis companies are Fresh Tracks Therapeutics, Inmagene, SFA Therapeutics, Palobiofarma, Sun Pharmaceutical Industries Limited, Biohaven Pharmaceuticals, Inc., Dr. Reddy’s, MetrioPharm, Celltrion, Amgen, Can-Fite Biopharma, and others. (Albany,

Read More

IgA Nephropathy Drugs Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Revenue, Statistics, Therapies, and Companies by DelveInsight

IgA Nephropathy Drugs Market IgA Nephropathy companies include Calliditas Therapeutics AB, Travere Therapeutics, Inc., Omeros Corporation, Novartis, RemeGen, Chinook Therapeutics, Inc., Vera Therapeutics, Inc., Otsuka Pharmaceutical, and others (Albany, USA)

Read More

Systemic Lupus Erythematosus Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight

Systemic Lupus Erythematosus Treatment Market Systemic Lupus Erythematosus companies are GlaxoSmithKline, AstraZeneca, Sanofi, Eli Lilly/Nektar Therapeutics, UCB Pharma, Hoffmann-La Roche, Biogen, ImmuPharma, Xencor, Bristol Myers Squibb, Alpine Immune Sciences, Johnson

Read More

NLRP3 Protein Inhibitors Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Medication, NDA Approval, IND, Mechanism of Action, Route of Administration by DelveInsigh

NLRP3 Protein Inhibitors Clinical Trials NLRP3 protein inhibitors companies are Halia Therapeutics, Ventus Therapeutics, EpicentRx, Zydus Lifesciences Limited, Monte Rosa Therapeutics, Inflammasome Therapeutics, Ventyx Biosciences, Biolexis Therapeutics, Halia Therapeutics, Olatec

Read More

MASH Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Statistics, Revenue, Patient Pool, MOA, ROA and Companies by DelveInsight

MASH Drugs Market MASH Companies are Hepion Pharmaceuticals, Ionis Pharmaceuticals, Galectin Therapeutics, Novo Nordisk A/S, Cirius Therapeutics, HighTide Biopharma, Boehringer Ingelheim, Hepagene, Eli Lilly and Company, Pfizer, Lipocine, Corcept Therapeutics,

Read More

Brenmiller Energy’s Edison Win Exposes the Market Is Sleeping on This Stock-But Expect an Imminent Wake-Up Call ($BNRG)

The energy transition space is full of noise. Headlines are crowded with eye-catching raises, buzzword-laden pitches, and future promises that may or may not materialize. But once in a while,

Read More